273- Fotherby MD, Potter JF. Effects of moderate sodium restriction on clinic and twenty-four- hour
ambulatory blood pressure in elderly hypertensive subjects. J Hypertens. 1993;11(6):657–63. - Gavras H, Waeber B, Kershaw GR, Liang CS, Textor SC, Brunner HR, Tifft CP, Gavras I. Role
of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients
with refractory hypertension. Hypertension. 1981;3:441–7. - Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA. Effects of
dietary sodium reduction on blood pressure in subjects with resistant hypertension: results
from a randomized trial. Hypertension. 2009;54(3):475–81. - McMahon EJ, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Johnson DW, Campbell
KL. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol.
2013;24(12):2096–103. - Campbell KL, Johnson DW, Bauer JD, Hawley CM, Isbel NM, Stowasser M, Whitehead
JP, Dimeski G, McMahon E. A randomized trial of sodium-restriction on kidney func-
tion, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014;15:57.
doi:10.1186/1471-2369-15-57. - Ok E. How to successfully achieve salt restriction in dialysis patients? What are the outcomes?
Blood Purif. 2010;29(2):102–4. - He FJ, Fan S, Macgregor GA, Yaqoob MM. Plasma sodium and blood pressure in individuals
on haemodialysis. J Hum Hypertens. 2013;27(2):85–9. - Lindley EJ. Reducing sodium intake in hemodialysis patients. Semin Dial. 2009;22(3):260–3.
- Inal S, Erten Y, Akbulu G, Oneç K, Tek NA, Sahin G, Okyay GU, Sanlier N. Salt intake and
hypervolemia in the development of hypertension in peritoneal dialysis patients. Adv Perit
Dial. 2012;28:10–5. - Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH,
Basci A, Ok E. The benefit of salt restriction in the treatment of end-stage renal disease by
haemodialysis. Nephrol Dial Transplant. 2009;24(3):956–62. - Magden K, Hur E, Yildiz G, Kose SB, Bicak S, Yildirim I, Sayin MR, Duman S. The effects
of strict salt control on blood pressure and cardiac condition in end-stage renal disease:
prospective- study. Ren Fail. 2013;35(10):1344–7. - Humalda JK, Navis G. Dietary sodium restriction: a neglected therapeutic opportunity in
chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23(6):533–40. - Krikken JA, Lely AT, Bakker SJ, Navis G. The effect of a shift in sodium intake on renal
hemodynamics is determined by body mass index in healthy youngmen. Kidney Int.
2007;71(3):260–5. - De Nicola L, Minutolo R, Gallo C, Zoccali C, Cianciaruso B, Conte M, Lupo A, Fuiano G,
Gallucci M, Bonomini M, Chiodini P, Signoriello G, Bellizzi V, Mallamaci F, Nappi F, Conte
G. Management of hypertension in chronic kidney disease: the Italian multicentric study.
J Nephrol. 2005;18(4):397–404. - McMahon EJ, Campbell KL, Mudge DW, Bauer JD. Achieving salt restriction in chronic kid-
ney disease. Int J Nephrol. 2012;2012:720429. - Institute of Medicine of the National Academies. Sodium intake in populations: assessment of
evidence. Washington, D.C.: The National Academies Press; 2013. - Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and
hydrochlorothiazide on the anti-proteinuric efficacy of losartan. J Am Soc Nephrol.
2008;19(5):999–1007. - Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N,
Saraheimo M, Gordin D. Groop PH; Finn Diane Study Group. The association between dietary
sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care.
2011;34(4):861–6. - O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma
AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk
of cardiovascular events. JAMA. 2011;306(20):2229–38.
16 Treatment of Hypertension in Light of the New Guidelines: Salt Intake